Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII

MeSH terms

• Blood Coagulation Factor Inhibitors / blood
• Coagulants / administration & dosage*
• Drug Administration Schedule
• Factor VII Deficiency / congenital
• Factor VII Deficiency / drug therapy*
• Factor VII Deficiency / immunology
• Factor VIIa / administration & dosage*
• Humans
• Infant
• Intracranial Hemorrhages / etiology
• Male
• Recombinant Proteins / administration & dosage
• Seizures / etiology
• Treatment Outcome